NCT06676267 Laparoscopic Surgical Systems for Gynecological and Remote Surgical Treatment.
| NCT ID | NCT06676267 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Affiliated Hospital of Nantong University |
| Condition | Gynecological Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 5 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5 participants in total. It began in 2024-08-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Remote robot-assisted laparoscopic surgery will be performed for gynecological surgical treatment through 5G network, while the safety and effectiveness will be studied.
Eligibility Criteria
Inclusion Criteria: * Patients who require endoscopic surgery * Voluntarily participate in this study and sign informed consent in writing Exclusion Criteria: * Patients with malignant tumors with clinical stage IV * Those who require emergency surgery * Presence of active bleeding, severe abnormal coagulopathy (prothrombin time (PT) or international normalized ratio (INR) greater than 1.5 times the upper limit of normal), or platelet count \< 80×10\^9/L * Patient has severe cardiovascular or circulatory disease and cannot tolerate surgery * Participated in other clinical trials in the past 1 month * Inability to understand trial requirements, or inability to complete the study follow-up plan * Other conditions that are considered by the investigator to be inappropriate for enrollment
Contact & Investigator
Minhui Hua, M.D.
PRINCIPAL INVESTIGATOR
Affiliated Hospital of Nantong University
Frequently Asked Questions
Who can join the NCT06676267 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Gynecological Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06676267 currently recruiting?
Yes, NCT06676267 is actively recruiting participants. Contact the research team at mh_hua@ntu.edu.cn for enrollment information.
Where is the NCT06676267 trial being conducted?
This trial is being conducted at Nantong, China.
Who is sponsoring the NCT06676267 clinical trial?
NCT06676267 is sponsored by Affiliated Hospital of Nantong University. The principal investigator is Minhui Hua, M.D. at Affiliated Hospital of Nantong University. The trial plans to enroll 5 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.